BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chand M, Keller DS, Mirnezami R, Bullock M, Bhangu A, Moran B, Tekkis PP, Brown G, Mirnezami A, Berho M. Novel biomarkers for patient stratification in colorectal cancer: A review of definitions, emerging concepts, and data. World J Gastrointest Oncol 2018; 10(7): 145-158 [PMID: 30079141 DOI: 10.4251/wjgo.v10.i7.145]
URL: https://www.wjgnet.com/1007-9327/full/v10/i7/145.htm
Number Citing Articles
1
Adewale Oluwaseun Fadaka, Ashley Pretorius, Ashwil Klein. Biomarkers for Stratification in Colorectal Cancer: MicroRNAsCancer Control 2019; 26(1): 107327481986278 doi: 10.1177/1073274819862784
2
Simrandeep Kaur, Karamjit S Gill, Mridu Manjari, Surinder Kumar, Shreya Nauhria, Reetuparna Nath, Chandni Patel, Kamal Hamdan, Yujin Jeong, Narendra P Nayak, Sabyasachi Maity, Rob Hilgers, Samal Nauhria. Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Colorectal Carcinoma: A Potential Area of Focus for Future DiagnosticsCureus 2022;  doi: 10.7759/cureus.22811
3
Mehmet Aydin, Remzi Kızıltan, Sermin Algul, Ozgur Kemik. The Utility of Serum Vasorin Levels as a Novel Potential Biomarker for Early Detection of Colon CancerCureus 2022;  doi: 10.7759/cureus.21653
4
Zhiyuan Lv, Shuo Wang, Wandong Zhao, Ningning He. MicroRNA analysis of NCI-60 human cancer cells indicates that miR-720 and miR-887 are potential therapeutic biomarkers for breast cancerDrug Discoveries & Therapeutics 2020; 14(4): 197 doi: 10.5582/ddt.2020.03058
5
Caterina Alfano, Lorenzo Farina, Manuela Petti. Networks as Biomarkers: Uses and PurposesGenes 2023; 14(2): 429 doi: 10.3390/genes14020429
6
Amanda N. Lisby, John C. Flickinger, Babar Bashir, Megan Weindorfer, Sanjna Shelukar, Madison Crutcher, Adam E. Snook, Scott A. Waldman. GUCY2C as a biomarker to target precision therapies for patients with colorectal cancerExpert Review of Precision Medicine and Drug Development 2021; 6(2): 117 doi: 10.1080/23808993.2021.1876518
7
Mehdi Azizi, Hadi Kokabi, Hassan Dianat-Moghadam, Mohammad Mehrmohammadi. Targeted Cancer Imaging2022; : 49 doi: 10.1016/B978-0-12-824513-2.00004-8
8
Hyung-Hoon Oh, Young-Eun Joo. Novel biomarkers for the diagnosis and prognosis of colorectal cancerIntestinal Research 2020; 18(2): 168 doi: 10.5217/ir.2019.00080
9
Emmanuel Bresso, Joao-Pedro Ferreira, Nicolas Girerd, Masatake Kobayashi, Grégoire Preud’homme, Patrick Rossignol, Fayez Zannad, Marie-Dominique Devignes, Malika Smaïl-Tabbone. Inductive database to support iterative data mining: Application to biomarker analysis on patient data in the Fight-HF projectJournal of Biomedical Informatics 2022; 135: 104212 doi: 10.1016/j.jbi.2022.104212
10
Harshabad Singh, Ashley Kang, Lisa Bloudek, Ling-I Hsu, Maria Corinna Palanca-Wessels, Michael Stecher, Muriel Siadak, Kimmie Ng. Systematic literature review and meta-analysis of HER2 amplification, overexpression, and positivity in colorectal cancerJNCI Cancer Spectrum 2024; 8(1) doi: 10.1093/jncics/pkad082
11
Anna La Salvia, Victoria Lopez-Gomez, Rocio Garcia-Carbonero. HER2-targeted therapy: an emerging strategy in advanced colorectal cancerExpert Opinion on Investigational Drugs 2019; 28(1): 29 doi: 10.1080/13543784.2019.1555583
12
Sonali Pal, Manoj Garg, Amit Kumar Pandey. Colon Cancer Diagnosis and Therapy2021; : 123 doi: 10.1007/978-3-030-63369-1_8
13
Qingtao Meng, Jing Wang, Bo Jiang, Xinwei Zhang, Jie Xu, Yuanyuan Cao, Hongbao Yang, Shenshen Wu, Na Gao, Yu Zhang, Jin Xu, Hanqing Chen, Xiaobo Li, Rui Chen. SiRNA-based delivery nanoplatform attenuates the CRC progression via HIF1α-AS2Nano Today 2022; 47: 101667 doi: 10.1016/j.nantod.2022.101667
14
Maryam Karkhane, Hamed Esmaeil Lashgarian, Maryam Hormozi, Shirzad Fallahi, Kourosh Cheraghipour, Abdolrazagh Marzban. Oncogenesis and Tumor Inhibition by MicroRNAs and its Potential Therapeutic Applications: A Systematic ReviewMicroRNA 2020; 9(3): 198 doi: 10.2174/2211536608666191104103834
15
Sun Bin Im, Jae Min Cho, Han Byul Kim, Dong-Hoon Shin, Myeong Sook Kwon, In Young Lee, Gyung Mo Son. FSP-1 expression in cancer cells is relevant to long-term oncological outcomes in nonmetastatic colorectal cancerKorean Journal of Clinical Oncology 2022; 18(2): 66 doi: 10.14216/kjco.22009
16
Wei Zhang, Xiao Jian Zhang, Shen Yan Chao, Su Juan Chen, Zi Jing Zhang, Jian Zhao, Ya Nan Lv, Jing Jie Yao, Yue Yu Bai. Update on urine as a biomarker in cancer: a necessary review of an old storyExpert Review of Molecular Diagnostics 2020; 20(5): 477 doi: 10.1080/14737159.2020.1743687
17
Tomas Bertok, Aniko Bertokova, Eduard Jane, Michal Hires, Juvissan Aguedo, Maria Potocarova, Ludovit Lukac, Alica Vikartovska, Peter Kasak, Lubor Borsig, Jan Tkac. Identification of Whole-Serum Glycobiomarkers for Colorectal Carcinoma Using Reverse-Phase Lectin MicroarrayFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.735338
18
Jen-Pin Chuang, Hsiang-Lin Tsai, Po-Jung Chen, Tsung-Kun Chang, Wei-Chih Su, Yung-Sung Yeh, Ching-Wen Huang, Jaw-Yuan Wang. Comprehensive Review of Biomarkers for the Treatment of Locally Advanced Colon CancerCells 2022; 11(23): 3744 doi: 10.3390/cells11233744
19
Alok Kumar, Pradyumn Singh, Anshuman Pandey, Sunil Babu Gosipatala. IGFBP3 gene promoter methylation analysis and its association with clinicopathological characteristics of colorectal carcinomaMolecular Biology Reports 2020; 47(9): 6919 doi: 10.1007/s11033-020-05747-2
20
Kholood Abid Janjua, Raheem Shahzad, Adeeb Shehzad. Cancer Biomarkers in Diagnosis and Therapeutics2022; : 277 doi: 10.1007/978-981-16-5759-7_11
21
Jie Xu, Qingtao Meng, Hao Sun, Xinwei Zhang, Jun Yun, Bin Li, Shenshen Wu, Xiaobo Li, Hongbao Yang, Haitao Zhu, Michael Aschner, Michela Relucenti, Giuseppe Familiari, Rui Chen. HER2-specific chimeric antigen receptor-T cells for targeted therapy of metastatic colorectal cancerCell Death & Disease 2021; 12(12) doi: 10.1038/s41419-021-04100-0
22
Jinjia Chang, Midie Xu, Chenchen Wang, Dan Huang, Zhe Zhang, Zhiyu Chen, Xiaodong Zhu, Wenhua Li. Dual HER2 Targeted Therapy With Pyrotinib and Trastuzumab in Refractory HER2 Positive Metastatic Colorectal Cancer: A Result From HER2-FUSCC-G StudyClinical Colorectal Cancer 2022; 21(4): 347 doi: 10.1016/j.clcc.2022.07.003
23
Jie Zhou, Ali Foroughi pour, Hany Deirawan, Fayez Daaboul, Thazin Nwe Aung, Rafic Beydoun, Fahad Shabbir Ahmed, Jeffrey H. Chuang. Integrative deep learning analysis improves colon adenocarcinoma patient stratification at risk for mortalityeBioMedicine 2023; 94: 104726 doi: 10.1016/j.ebiom.2023.104726
24
Jie Xu, Qingtao Meng, Xiaobo Li, Hongbao Yang, Jin Xu, Na Gao, Hao Sun, Shenshen Wu, Giuseppe Familiari, Michela Relucenti, Haitao Zhu, Jiong Wu, Rui Chen. Long Noncoding RNA MIR17HG Promotes Colorectal Cancer Progression via miR-17-5pCancer Research 2019; 79(19): 4882 doi: 10.1158/0008-5472.CAN-18-3880
25
Chi-Cheng Huang, Ming-Hung Shen, Shao-Kuan Chen, Shung-Haur Yang, Chih-Yi Liu, Jiun-Wen Guo, Kang-Wei Chang, Chi-Jung Huang. Gut butyrate-producing organisms correlate to Placenta Specific 8 protein: Importance to colorectal cancer progressionJournal of Advanced Research 2020; 22: 7 doi: 10.1016/j.jare.2019.11.005
26
Mehdi Azizi, Hassan Dianat‐Moghadam, Roya Salehi, Masoud Farshbaf, Disha Iyengar, Samaresh Sau, Arun K. Iyer, Hadi Valizadeh, Mohammad Mehrmohammadi, Michael R. Hamblin. Interactions Between Tumor Biology and Targeted Nanoplatforms for Imaging ApplicationsAdvanced Functional Materials 2020; 30(19) doi: 10.1002/adfm.201910402
27
Thanh Trung Giang, Thanh-Phuong Nguyen, Quang Trung Pham, Dang Hung Tran. Soft Computing: Biomedical and Related ApplicationsStudies in Computational Intelligence 2021; 981: 21 doi: 10.1007/978-3-030-76620-7_2
28
Shreya Beniwal, Paula Lamo, Ajeet Kaushik, Dionisio Lorenzo-Villegas, Yuguang Liu, ArunSundar MohanaSundaram. Current Status and Emerging Trends in Colorectal Cancer Screening and DiagnosticsBiosensors 2023; 13(10): 926 doi: 10.3390/bios13100926